Related references
Note: Only part of the references are listed.Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
Michael Grever et al.
LEUKEMIA (2021)
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia
Enrico Tiacci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Usefulness of Dual Immunohistochemistry Staining in Detection of Hairy Cell Leukemia in Bone Marrow
Gaurav K. Gupta et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Robert J. Kreitman et al.
LEUKEMIA (2018)
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
Michael R. Grever et al.
BLOOD (2017)
Immunohistochemical Detection of Hairy Cell Leukemia in Paraffin Sections The Role of Pax5 and CD103 Double Staining to Improve Specificity and Sensitivity
Igor B. Rozenvald et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Long-term follow-up after purine analogue therapy in hairy cell leukaemia
Monica Else et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2015)
Historical overview of hairy cell leukemia
Leslie A. Andritsos et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2015)
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia
E. Tiacci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Is it really possible to cure hairy cell leukemia patients only with frontline therapy?
Pier Luigi Zinzani et al.
ANNALS OF HEMATOLOGY (2014)
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients
Pier Luigi Zinzani et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2012)
BRAF Mutations in Hairy-Cell Leukemia
Enrico Tiacci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine
Darren S. Sigal et al.
BLOOD (2010)
Hairy Cell Leukemia Evaluation of the Long-Term Outcome in 121 Patients
Pier Luigi Zinzani et al.
CANCER (2010)
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
Monica Else et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)
R. Zenhaeusern et al.
LEUKEMIA & LYMPHOMA (2009)
Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98)
Reinhard Zenhaeusern et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial
Tadeusz Robak et al.
BLOOD (2007)
Cladribine in hairy cell leukemia
Rajesh Belani et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2006)
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience
P Chadha et al.
BLOOD (2005)
An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine
U Jehn et al.
LEUKEMIA (2004)
Extended follow-up of patients with hairy cell leukemia after treatment with cladribine
GR Goodman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Efficacy of rituximab in hairy cell leukemia treatment
PL Zinzani et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
